Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

MarketScreener
marketscreener.com > news > novocure-ltd-announces-retirement-of-timothy-scannell-from-the-board-effective-september-2-2026-ce785bd9d18af020

Novocure Ltd Announces Retirement of Timothy Scannell from the Board, Effective September 2, 2026

3+ day, 11+ hour ago   (82+ words) marketscreener.com Published on 09/09/2026 at 11:51 am EDT NovoCure Ltd. announced that Timothy Scannell, a current director of NovoCure Ltd, retired from the Board and his seat was formally vacated pursuant to the Company's Articles of Association effective September 2, 2026. Mr. Scannell's…...

@yogonetNews
yogonet.com > international > news > 09/03/2026 > 126202-novomatic-named-business-superbrand-austria-for-20262027

NOVOMATIC named Business Superbrand Austria for 2026/2027 | Yogonet International

1+ week, 2+ day ago   (172+ words) The autonomous panel of experts evaluates consumer and business brands in approximately 90 countries on the basis of a set of internationally standardized criteria. Through the accolade, NOVOMATIC has once again been named one of Austria’s most powerful brands. “This latest…...

BioSpace
biospace.com > press-releases > novocure-announces-upcoming-september-2026-investor-events

Novocure Announces Upcoming September 2026 Investor Events

1+ week, 3+ day ago   (262+ words) BioSpace Novocure Announces Upcoming September 2026 Investor Events BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor events. - Wells Fargo 21st Annual Healthcare Conference, September 9, 2026: Frank Leonard, Chief Executive Officer, will take part in…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > ango-buy-med-tech-growth-181600738.html

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

1+ mon, 6+ day ago   (495+ words) AngioDynamics, Inc. ANGO offers investors a clear trade-off. Its Med Tech platforms are expanding quickly, but near-term earnings conversion remains weak as tariffs and operating costs absorb part of the benefit. The investment case depends on whether NanoKnife, Auryon and…...

TASS
tass.com > economy > 2167775

Nornickel’s net profit more than doubles to $2 bln in 1H

1+ mon, 1+ week ago   (214+ words) Revenue rose by 28% in the reporting period to $8.3 bln - Russian Politics & Diplomacy Russian Politics & DiplomacyInto section →- Business & Economy Business & EconomyInto section → - Military & Defense Military & DefenseInto section → - Science & Space Science & SpaceInto section → - Society & Culture Society & CultureInto section…...

Quantum Commodity Intelligence
qcintel.com > article > nis-profit-rebounds-as-pancevo-refinery-resumes-processing-70030.html

NIS profit rebounds as Pancevo refinery resumes processing

1+ mon, 1+ week ago   (65+ words) Quantum Commodity Intelligence NIS profit rebounds as Pancevo refinery resumes processing Quantum Commodity Intelligence is a premium paid subscription service for professionals in the oil, biofuels, carbon, ammonia and hydrogen markets. - Quantum Oil Daily - market report sent to your email…...

TradingView
tradingview.com > news > urn:summary_document_report:quartr.com:3692905:0-nucleus-q1-fy27-saw-lower-revenue-and-profit-impacted-by-exceptional-employee-benefit-items

NUCLEUS: Q1 FY27 saw lower revenue and profit, impacted by exceptional employee benefit items

1+ mon, 1+ week ago   (79+ words) TradingView NUCLEUS: Q1 FY27 saw lower revenue and profit, impacted by exceptional employee benefit items Revenue and profit declined both sequentially and year-over-year, with consolidated net profit at ₹2,387 lakhs and revenue at ₹21,043 lakhs for Q1 FY27. Exceptional items from revised employee benefit liabilities impacted…...

@kalkineus
kalkinemedia.com > us > news > announcements > neo-reports-q2-2026-financial-results-and-details-on-convertible-notes-due-2032

Neo Reports Q2 2026 Financial Results and Details on Convertible Notes Due 2032

1+ mon, 2+ week ago   (33+ words) Kalkine Media Commvault Systems (NASDAQ:CVLT) Faces A Growth Test Is Intel (NASDAQ:INTC) Ready for Its Next Big Challenge?...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:3914213:0-neo-q2-revenue-up-11-with-strong-clinical-and-ngs-growth-guidance-raised-for-2026

NEO: Q2 revenue up 11% with strong clinical and NGS growth; guidance raised for 2026

1+ mon, 2+ week ago   (79+ words) TradingView NEO: Q2 revenue up 11% with strong clinical and NGS growth; guidance raised for 2026 Q2 2026 revenue rose 11% year-over-year to $201.7M, led by 14% clinical growth and 26% NGS growth. Gross margin expanded 260 bps, and adjusted EBITDA grew 36%. Full-year guidance was raised, with continued investment in…...

@LondonSouthEast
lse.co.uk > rns > NTVO > placing-and-subscription-to-raise-163640000-polx3yo2cshpmly.html

Nativo Resources Regulatory News. Live NTVO RNS. Regulatory News Articles for Nativo Resources Plc Ord 0.15p

1+ mon, 2+ week ago   (958+ words) Discover Judith MacKenzie's approach to finding long-term UK small-cap winners. Watch here ("Nativo" or the "Company") Placing and Subscription to Raise £640,000 Retail Offer to Shareholders of up to £60,000 Through BookBuild · To advance Plant construction works, procurement and EPC contractor engagement,…...